Prescription Drug Monitoring Program. A Powerful Tool
|
|
|
- Claude Banks
- 10 years ago
- Views:
Transcription
1 Prescription Drug Monitoring Program A Powerful Tool September 16, 2015
2 No reportable financial interest.
3 Controlled Substance Utilization Review and Evaluation System
4 >16,000 Prescription Painkiller Overdose Deaths (CY 2013)
5
6
7
8 U.S. Air Force Instruction (AFI) The Two Person Concept is designed to prevent accidental or malicious launch of nuclear weapons by a single individual.
9 Two keys to prescription acquisition The Prescriber The Dispenser
10
11
12 CURES History 1939 The California Triplicate Prescription Program (TPP) was created, capturing Schedule II prescription information CURES was initiated, operating in parallel with the TPP s Automated Triplicate Prescription System (ATPS) to evaluate the comparative efficiencies between the two systems TPP/ATPS decommissioned after Senate Bill 151 eliminated the triplicate prescription requirement for Schedule II controlled substances, making CURES permanent. Schedule III controlled substance prescription reporting became required Schedule IV controlled substance prescription reporting became required PDMP was introduced as a searchable, client-facing component of CURES The Bureau of Narcotic Enforcement dissolved and the CURES Program was de-funded CURES 2.0 went live.
13 Relevant Provisions of Law Health Insurance Portability and Accountability Act (HIPAA) & Attendant Regulations 42 U.S.C. 1320d to 1320d-8, and 45 CFR 164, et seq. California Confidentiality of Medical Information Act CA Civil Code 56 to California Information Practices Act CA Civil Code 1798, et seq. CURES Legislation CA Health and Safety Code 11165, et seq.
14 CURES System and Requirements Pharmacies and dispensers are required to report dispensations of Schedules II through IV controlled substances to DOJ at least weekly. California Healthy & Safety Code section 11165(d) Presently, the database contains over 230 million entries of controlled substance prescriptions dispensed in California. In order to reflect exactly what dispensers report to DOJ, the department does not touch or modify dispenserreported data.
15 CURES System and Requirements Access to CURES is restricted to: Licensed prescribers and licensed pharmacists strictly for patients in their direct care Law enforcement for criminal investigatory purposes Regulatory boards for oversight and disciplinary purposes California Healthy & Safety Code section 11165(a)
16 CURES System and Requirements On Sept. 27, 2013, Senate Bill 809 passed requiring prescribers and pharmacists to apply for CURES access. A health care practitioner authorized to prescribe, order, administer, furnish, or dispense Schedule II, Schedule III, or Schedule IV controlled substances shall, before January 1, 2016, or upon receipt of a federal DEA registration, whichever occurs later, submit an application to obtain approval to access CURES. California Healthy & Safety Code section (a)(1)(a)(i) A pharmacist shall, before January 1, 2016, or upon licensure, whichever occurs later, submit an application to obtain approval to access CURES. California Healthy & Safety Code section (a)(1)(a)(ii) Use of CURES by prescribers and dispensers for prescription abuse prevention/intervention is voluntarily.
17 PDMP Enrollment Dentists 37,494 Medical Physicians 128,697 Optometrists 4,939 Osteopathic Physicians 6,376 Physician Assistants 8,520 Podiatrists 1,918 Registered Nurse Midwives (Furnishing) 778 Registered Nurse Practitioners (Furnishing) 12,125 Veterinarians 10,985 Prescribers 174,338 Pharmacists 38,293 ============================ TOTAL 212,631 PDMP Registrants 52,134 (As of 09/15/2015)
18 CURES Registration September 15, ,134 Registrants 606.2% December, ,600 Registrants
19 CURES 2.0 System CURES 2.0 went live on July 1, Soft Launch and Phased Rollout Internet Web Browser Requirement Microsoft Internet Explorer 11 or greater Google Chrome Mozilla Firefox Safari
20 CURES 2.0 Registration Existing CURES 1.0 users do not need to re-register for CURES 2.0. Select User Role License Issued by: CA DCA Agency outside of CA Enter address (twice) Enter CAPTCHA
21 CURES 2.0 Registration Applicant receives an with instructions and link to the Registration page. The link is valid for 90 days. CA licensees will no longer need to notarize and mail paper applications.
22 CURES 2.0 Registration Approved users are sent an with their User ID and link to validate identification. Then the user is sent an with their Temporary Password. Upon first-time login, the user must reset their Password and complete their profile.
23 CURES 2.0 Features User Profile Management Update Profile Manage Delegates Change Password Patient Activity Reports (PARs) PDF or Download to Excel Saved Searches Prescription Form Theft/Loss Report View Self-reports
24 CURES 2.0 Features Delegates Prescribers and dispensers register delegates and assume responsibility for delegates use of CURES 2.0. Delegates may initiate PAR searches on behalf of their Parent prescriber or dispenser. Prescribers and dispensers may have several delegates. And delegates can support several prescribers and dispensers. Delegates are deleted when they have not been associated with any CURES users for 30 days or if the delegate has not logged into CURES for 12 months.
25 CURES 2.0 Features Compacts Providers can flag patients within CURES 2.0 with whom they have an exclusivity compact. Users can view if a compact exists for a patient. Peer-to-Peer Communication Users can view prescriber contact information on PAR Details pages. Prescribers and dispensers can send messages to prescribers within CURES 2.0. Contact information is based on CURES enrollment.
26 CURES 2.0 Features Alerts Based on patterns indicative of at-risk patient behavior. Alerts are informational and providers must determine if any action is necessary.
27 CURES 2.0 Features Alerts 1. Currently prescribed more than 100 mme per day. 2. Obtained prescriptions from 6 or more prescribers or pharmacies in the last 6 months. 3. Currently prescribed 40 or more mme of Methadone daily. 4. Currently prescribed Opioids more than 90 consecutive days. 5. Currently prescribed both Benzodiazepines and Opioids.
28 CURES 2.0 Self-Service Password resets are required every 90 days. Reminder s and on-screen warnings will be presented to the user prior to password expiration.
29 CURES 2.0 Resources User Guide Training Videos
30 CURES 2.0 CURES 2.0 registration is coming soon. Practitioners and health systems should begin to prepare for CURES 2.0 by meeting CURES 2.0 security standards, i.e. UPDATE YOUR WEB BROWSERS. Microsoft Internet Explorer 11 or greater Google Chrome Mozilla Firefox Safari
31 QUESTIONS?
32 CURES Program Contacts California Department of Justice PDMP/CURES P.O. Box Sacramento, California Phone: (916) FAX: (916)
33 CURES Program Contacts Tina Farales, Manager Phone: (916)
34 thank you!
CURES Prescription Drug Monitoring Program
California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug
Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:
Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain
3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:
Commonwealth of Massachusetts Department of Public Health, Office of Prescription Monitoring and Drug Control 99 Chauncy Street, Boston, MA 02111 Tel: 617-753-7310 Email: [email protected] MA ONLINE
Implementation of Florida s PDMP. Rebecca Poston Program Manager
Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:
State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual
State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program User Support Manual Contents 1 What Is a Requestor?... 3 2 Registration... 4 2.1 Registration Process... 4 2.2 Registering as
Prescribers required to check PDMP before first prescription for Controled Substances for new patient.
State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,
Alaska Prescription Drug Monitoring Program
Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this
CHAPTER 74. 1. Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:
CHAPTER 74 AN ACT concerning drug abuse, revising various parts of the statutory law, and supplementing P.L.2007, c.244. BE IT ENACTED by the Senate and General Assembly of the State of New Jersey: 1.
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this
I-STOP: What You Need to Know. Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013
I-STOP: What You Need to Know Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013 What is I-STOP? Objectives Why is I-STOP necessary and how is it relevant
SCOPE OF PRACTICE FOR ARNPS
FLORIDA'S PROHIBITION ON ADVANCED REGISTERED NURSE PRACTITIONERS (ARNPs) PRESCRIBING CONTROLLED SUBSTANCES AND THE REQUIREMENTS TO REPORT SUCH ACTIVITY Florida is one of the two states that does not allow
How to Utilize the Security Portal to Access PDMP (User Guide for Practitioners, Pharmacists, CRNPs, Physician Assistants, Law Enforcement, and CNMs)
How to Utilize the Security Portal to Access PDMP (User Guide for Practitioners, Pharmacists, CRNPs, Physician Assistants, Law Enforcement, and CNMs) July 30, 2014 Version 2 Software Release Version 3.4.11
PMP AWAR X E. User Support Manual V 1.2
PMP AWAR X E User Support Manual V 1.2 04/09/2014 1 Contents 1 What Is a Requestor?... 3 2 Registration... 3 2.1 Registration Process... 3 2.2 Registering as a Delegate... 7 2.3 Email Verification... 11
Washington. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington
PDMP User s Guide. Oregon Health Authority Prescription Drug Monitoring Program
Oregon Health Authority Prescription Drug Monitoring Program December 2015 Contents Contents 1 Document Overview... 1 Purpose and Contents... 1 RxSentry Update... 1 2 System Overview... 3 About the RxSentry
FREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic Online PMP Q: What is
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
Training Guide for Florida Practitioners and Pharmacists
Training Guide for Florida Practitioners and Pharmacists Florida Department of Health Prescription Drug Monitoring Program March 2014 Note This document is periodically updated. Please refer to the Florida
2010-2011 Prescription Drug Monitoring Program Annual Report
2010-2011 Prescription Drug Monitoring Program Annual Report Prescription Drug Monitoring Program E-FORCSE 4052 Bald Cypress Way, Bin C-16 Tallahassee, FL 32399 (850) 245-4444 X 3700 December 1, 2011 Prescription
Massachusetts. Contact Information. Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - Assistant Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8104 Fax: (617) 524-8062 Email: ASAP Versions Accepted
Training Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program
Training Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program August 2014 v1.7 Contents Contents 1 Document Overview... 1 Purpose
PLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.
PLEASE READ The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.us/ New Jersey Statutes Annotated (N.J.S.A.), published by
Prescription Drug Monitoring Program Center of Excellence at Brandeis
Prescription Drug Monitoring Program Center of Excellence at Brandeis Notes from the Field NF 4.1 Using PDMPs to Improve Medical Care: Washington State s Data Sharing Initiative with Medicaid and Workers
2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
Georgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Higgins, Ronnie - Special Agent 40 Pryor St SW, Ste 2000 Atlanta GA 30303 Office: (404) 656-5100 Fax: (404) 651-8210 Email: [email protected]
Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY
2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...
Idaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Idaho Board of Pharmacy Pharmacy Board http://idaho.pmpaware.net [email protected] Anderson, Teresa - Program Information Coordinator
Electronic Prescribing In New York State
Electronic Prescribing In New York State Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 Overview Review the problem & e-prescribing mandate Describe
ANALYSIS AS REPORTED FROM COMMITTEE
PHARMACY TECHNICIAN LICENSURE S.B. 92 (S-5): ANALYSIS AS REPORTED FROM COMMITTEE Senate Bill 92 (Substitute S-5 as reported by the Committee of the Whole) (as passed by the Senate) Sponsor: Senator Mike
NH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
Texas Board of Nursing Update
Texas Board of Nursing Update Texas Organization of Nurse Executives Annual Conference April 4, 2014 Kristin Benton, MSN, RN Director of Nursing Texas Board of Nursing Objectives 1. Discuss national changes
Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement
Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement 2013 Telephone: (781) 609-7741 Fax: (888) 705-8053 Email: [email protected] Website: www.pdmpassist.org INTRODUCTION
HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 103 Medicinal Drug Prescriptions SPONSOR(S): Quinones TIED BILLS: IDEN./SIM. BILLS: SB 132 (i) REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care
Prescription Drug Abuse and Pain Management Clinics 2015 Report to the 109 th Tennessee General Assembly
Prescription Drug Abuse and Pain Management Clinics 2015 Report to the 109 th Tennessee General Assembly Andrea Huddleston, Chief Deputy General Counsel Tennessee Department of Health Office of General
(128th General Assembly) (Amended Substitute Senate Bill Number 89) AN ACT
(128th General Assembly) (Amended Substitute Senate Bill Number 89) AN ACT To amend sections 4723.01, 4723.06, 4723.48, 4723.482, and 4723.50; to amend, for the purpose of adopting new section numbers
PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED
PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED Senate Bill 92 (as enacted) PUBLIC ACT 285 of 2014 Sponsor: Senator Mike Green Senate Committee: Regulatory Reform House Committee: Health Policy
11/26/2012. Implementation of Florida s PDMP. Disclosure
Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or
E-Prescribing of Controlled Substances (EPCS) New York State Board for Podiatry
E-Prescribing of Controlled Substances (EPCS) As of March 27, 2015 it will be mandatory for practitioners, excluding veterinarians, to issue electronic prescriptions for controlled and non-controlled substances.
PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA
PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
NOTICES OF PROPOSED RULEMAKING
NOTICES OF PROPOSED RULEMAKING Unless exempted by A.R.S. 41-1005, each agency shall begin the rulemaking process by first submitting to the Secretary of State s Office a Notice of Rulemaking Docket Opening
Substance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Jackson, Kate - PDMP Manager 55 Wade Ave Catonsville MD 21228 Office: (410) 402-8609 Fax: (410) 402-8601 Email: Maryland Department
Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Delaware Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency Nettesheim, Samantha -
Training Guide for Government Agencies and Healthcare Administration
Training Guide for Government Agencies and Healthcare Administration Pharmacy Examining Board Wisconsin Department of Safety and Professional Services May 2013 Contents Contents 1 Document Overview...
State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations
State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations There is currently an epidemic of prescription opioid abuse, misuse and diversion in the U.S. Numerous federal,
Administrative Policy
Administrative Policy Number: 411 Effective: 4/7/2011 Supersedes: n/a Page: 1 of 8 Subject: Use of Controlled Substances in Research 1.0. PURPOSE: The purpose of this policy is to set forth procedures
May a company designate any of this information as trade secret?
Introduction GUIDE TO VERMONT S PHARMACEUTICAL MARKETING DISCLOSURE LAW FOR FY09 DISCLOSURES Published by the Vermont Office of the Attorney General 10/09/09 Effective July 1, 2009, Vermont law bans certain
South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives
South Dakota Prescription Drug Monitoring Program (SD PDMP) SD Academy of Physician Assistants Summer/Fall CME Conference September 6, 2012 Ron Huether, RPh, SD PDMP Kari Shanard Koenders, RPh, PDMP Director
Table of Contents. User Request for Access... 3. User Login... 3. Upload a Data File... 4
Table of Contents User Request for Access... 3 User Login... 3 Upload a Data File... 4 Add Patient Records Direct Dispenser Users... 5 Pharmacy... 8 Search for Patient Records... 10 Search for Error Records...
State of Utah Department of Commerce Division of Occupational and Professional Licensing
State of Utah Department of Commerce Division of Occupational and Professional Licensing Official Use Only Number: Date Approved/Denied: Approved/Denied By: Retired Volunteer Health Care Practitioner APPLICANT
Narcotic Treatment Programs
This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act
CHAPTER 10. 1. Section 3 of P.L.2013, c.46 (C.24:6J-3) is amended to read as follows:
CHAPTER 10 AN ACT concerning overdose prevention and sterile syringe access programs, and amending P.L.2006, c.99 and P.L.2013, c.46. BE IT ENACTED by the Senate and General Assembly of the State of New
The Massachusetts Prescription Monitoring Program
The Massachusetts Prescription Monitoring Program A Report to the Massachusetts General Court February 2015 Governor Charles D. Baker Secretary of Health and Human Services Marylou Sudders Massachusetts
What Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that
Global UGRAD Program
Application Instructions for Global UGRAD 2016-2017 Portal Step-by-Step I. REGISTERING FOR THE PROGRAM Google Chrome and Mozilla Firefox work best when completing the UGRAD application. We do NOT recommend
Mandating PDMP participation by medical providers: current status and experience in selected states
Prescription Drug Monitoring Program Center of Excellence at Brandeis COE Briefing Mandating PDMP participation by medical providers: current status and experience in selected states Revision 1, February
2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS
2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS Research current through September 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy.
64th Legislature AN ACT REVISING BOARD OF NURSING LAWS; PROVIDING FOR NURSING APPLICANTS TO SUBMIT TO
64th Legislature HB0115 AN ACT REVISING BOARD OF NURSING LAWS; PROVIDING FOR NURSING APPLICANTS TO SUBMIT TO CRIMINAL BACKGROUND CHECKS; EXPANDING THE NURSING MEDICAL ASSISTANCE PROGRAM TO ALL LICENSEES;
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE April 8, 2011 EFFECTIVE DATE April 8, 2011 MEDICAL ASSISTANCE BULLETIN NUMBER 03-11-01, 09-11-02, 14-11-01, 18-11-01 24-11-03, 27-11-02, 31-11-02, 33-11-02 SUBJECT Electronic Prescribing Internet-based
Gen. 253] 253 HEALTH OCCUPATIONS. November 28, 2001
Gen. 253] 253 HEALTH OCCUPATIONS PHARMACISTS PHYSICIANS ANTITRUST COLLABORATIVE AGREEMENTS BETWEEN PHARMACISTS AND PHYSICIANS RELATING TO DRUG THERAPY November 28, 2001 Ms. LaVerne G. Naesea Executive
New Jersey. Contact Information. Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Mielo, James - Administrator 124 Halsey St Newark NJ 07102 Office: (973) 273-8010 Fax: Email: NJPMRS [email protected] ASAP
ARIZONA STATE SENATE Fifty-Second Legislature, Second Regular Session
Assigned to HHS FOR COMMITTEE ARIZONA STATE SENATE Fifty-Second Legislature, Second Regular Session FACT SHEET FOR registered nurses; advanced practice Purpose Modifies statutes related to the licensing
WellDyneRx Mail Service General Questions and Answers
WellDyneRx Mail Service General Questions and Answers I. Location/ Hours of Operation 1. Where is WellDyneRx Mail Pharmacy located? WellDyneRx mail pharmacy has two locations: 1) Centennial, CO, a suburb
JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.
THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature
Prescription Drug Monitoring Programs Bill Status Update
Prescription Drug Monitoring Programs Bill Status Update Research current through February 24, 2015. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
STATE OF NEBRASKA STATUTES RELATING TO NURSE PRACTITIONER PRACTICE ACT
2013 STATE OF NEBRASKA STATUTES RELATING TO NURSE PRACTITIONER PRACTICE ACT Department of Health and Human Services Division of Public Health Licensure Unit 301 Centennial Mall South, Third Floor PO Box
NetClient CS Document Management Portal User Guide. version 9.x
NetClient CS Document Management Portal User Guide version 9.x TL 23560 (6/9/11) Copyright Information Text copyright 2001-2011 by Thomson Reuters/Tax & Accounting. All rights reserved. Video display images
Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System
0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill
Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC
Pharmacy Operations Assisting the Pharmacist Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, Assisting the Pharmacist PassAssured's Pharmacy Technician Training Program Pharmacy
House Study Bill 503 - Introduced
House Study Bill 0 - Introduced HOUSE FILE BY (PROPOSED COMMITTEE ON HUMAN RESOURCES BILL BY CHAIRPERSON MILLER) A BILL FOR An Act relating to prescription authority for certain psychologists and making
